Search for other papers by Henri Honka in
Google Scholar
PubMed
Department of Gastroenterology, Turku University Hospital, Turku, Finland
Search for other papers by Jukka Koffert in
Google Scholar
PubMed
Search for other papers by Saila Kauhanen in
Google Scholar
PubMed
Search for other papers by Nobuyuki Kudomi in
Google Scholar
PubMed
Search for other papers by Saija Hurme in
Google Scholar
PubMed
Search for other papers by Andrea Mari in
Google Scholar
PubMed
Search for other papers by Andreas Lindqvist in
Google Scholar
PubMed
Search for other papers by Nils Wierup in
Google Scholar
PubMed
Search for other papers by Riitta Parkkola in
Google Scholar
PubMed
Search for other papers by Leif Groop in
Google Scholar
PubMed
Department of Endocrinology, Turku University Hospital, Turku, Finland
Search for other papers by Pirjo Nuutila in
Google Scholar
PubMed
and sensitivity, and glycemic control, with no difference between RYGB and VSG groups (Supplementary Table 1, see section on supplementary data given at the end of this article). After surgery, five subjects had normal glucose tolerance and only two
Search for other papers by Jiaxi Li in
Google Scholar
PubMed
Search for other papers by Pu Huang in
Google Scholar
PubMed
Search for other papers by Jing Xiong in
Google Scholar
PubMed
Search for other papers by Xinyue Liang in
Google Scholar
PubMed
Search for other papers by Mei Li in
Google Scholar
PubMed
Search for other papers by Hao Ke in
Google Scholar
PubMed
Search for other papers by Chunli Chen in
Google Scholar
PubMed
Search for other papers by Yang Han in
Google Scholar
PubMed
Search for other papers by Yanhong Huang in
Google Scholar
PubMed
Search for other papers by Yan Zhou in
Google Scholar
PubMed
Hunan Key Laboratory of Organ Fibrosis, Central South University, Changsha, Hunan, China
Search for other papers by Ziqiang Luo in
Google Scholar
PubMed
Hunan Key Laboratory of Organ Fibrosis, Central South University, Changsha, Hunan, China
Search for other papers by Dandan Feng in
Google Scholar
PubMed
Search for other papers by Chen Chen in
Google Scholar
PubMed
ratio of Ghrelin/LEAP2 may provide another useful index of glycemic control and diabetic progress. Therefore, the purpose of this study is to measure serum ghrelin and LEAP2 levels in T2D patients and to evaluate their correlations with age, gender
Search for other papers by Metin Guclu in
Google Scholar
PubMed
Search for other papers by Sinem Kiyici in
Google Scholar
PubMed
Search for other papers by Zulfiye Gul in
Google Scholar
PubMed
Search for other papers by Sinan Cavun in
Google Scholar
PubMed
Introduction Excess weight and weight gain are significant problems in the treatment of patients with type 2 diabetes mellitus ( 1 ). Weight reduction is a critical part of type 2 diabetic patients’ management to obtain better glycemic control
Search for other papers by Lars Peter Sørensen in
Google Scholar
PubMed
Search for other papers by Tina Parkner in
Google Scholar
PubMed
Search for other papers by Esben Søndergaard in
Google Scholar
PubMed
Search for other papers by Bo Martin Bibby in
Google Scholar
PubMed
Search for other papers by Holger Jon Møller in
Google Scholar
PubMed
Search for other papers by Søren Nielsen in
Google Scholar
PubMed
) . Interestingly, in our study including subjects with NGT, IGT, and T2DM, sCD163 as well as TNFα, IL6, and CRP concentrations increased with deteriorating glycemic control even though the groups were BMI matched (BMI ∼30 kg/m 2 ) (24) . To the extent sCD163
Search for other papers by Emanuela Zaharieva in
Google Scholar
PubMed
Search for other papers by Zdravko Kamenov in
Google Scholar
PubMed
Search for other papers by Tsvetelina Velikova in
Google Scholar
PubMed
Search for other papers by Adelina Tsakova in
Google Scholar
PubMed
Search for other papers by Yosif El-Darawish in
Google Scholar
PubMed
Search for other papers by Haruki Okamura in
Google Scholar
PubMed
), considered by many an indistinguishable part of type 1 diabetes (T1D) ( 10 , 11 , 60 ), usually present with a better metabolic profile and inflammatory markers than T2D, even though optimal glycemic control is usually harder to achieve ( 12 ). Like other
Search for other papers by Xiuzhen Zhang in
Google Scholar
PubMed
Search for other papers by Dan Xu in
Google Scholar
PubMed
Search for other papers by Ping Xu in
Google Scholar
PubMed
Search for other papers by Shufen Yang in
Google Scholar
PubMed
Search for other papers by Qingmei Zhang in
Google Scholar
PubMed
Search for other papers by Yan Wu in
Google Scholar
PubMed
Search for other papers by Fengyi Yuan in
Google Scholar
PubMed
atherosclerosis in T1DM patients, which was primarily ascribed to the reduction in hemoglobin A1c (HbA1c) level ( 5 ). As the standard metric of glycemic control, the HbA1c level is ideally maintained as close to normal as possible for the purpose of reducing the
Mary & Dick Allen Diabetes Center at Hoag Hospital, Newport Beach, California, USA
Search for other papers by David Q Pham in
Google Scholar
PubMed
Search for other papers by Ashley Thorsell in
Google Scholar
PubMed
Search for other papers by Kristin Castorino in
Google Scholar
PubMed
Search for other papers by Brandon Cobb in
Google Scholar
PubMed
hyperglycemia in third trimester, reduced LGA, less NICU admissions and less neonatal hypoglycemia 3. Feig et al. Diabetes Care (2018) ( 11 ) Prespecified analysis of secondary outcome measure Compare pumps vs MDI outcomes including glycemic control
Search for other papers by Henry Zelada in
Google Scholar
PubMed
Search for other papers by M Citlalli Perez-Guzman in
Google Scholar
PubMed
Search for other papers by Daniel R Chernavvsky in
Google Scholar
PubMed
Search for other papers by Rodolfo J Galindo in
Google Scholar
PubMed
Introduction Evolution of glycemic control in the hospital The management of dysglycemia in the hospital has undergone a significant evolution over the last 30 years, with changes in glucose targets, advances in technology, and increased
Search for other papers by Annieke C G van Baar in
Google Scholar
PubMed
Search for other papers by Andrei Prodan in
Google Scholar
PubMed
Search for other papers by Camilla D Wahlgren in
Google Scholar
PubMed
Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Steen S Poulsen in
Google Scholar
PubMed
Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Filip K Knop in
Google Scholar
PubMed
Department of Laboratory Medicine, University of Groningen, University Medical Center, Groningen, the Netherlands
Search for other papers by Albert K Groen in
Google Scholar
PubMed
Search for other papers by Jacques J Bergman in
Google Scholar
PubMed
Department of Internal Medicine, VUMC Free University, Amsterdam, the Netherlands
Wallenberg Laboratory, Sahlgrenska Hospital, University of Gothenburg, Gothenburg, Sweden
Search for other papers by Max Nieuwdorp in
Google Scholar
PubMed
Horaizon BV, Delft, the Netherlands
Search for other papers by Evgeni Levin in
Google Scholar
PubMed
parameters in MetS (links in Fig. 4 ). L cell density correlated strongest with SDMA. This metabolite was reported to decrease in subjects with poor glycemic control ( 18 ). In our study, we found a positive correlation between SDMA and duodenal L cell
Search for other papers by Jared G Friedman in
Google Scholar
PubMed
Search for other papers by Kasey Coyne in
Google Scholar
PubMed
Search for other papers by Grazia Aleppo in
Google Scholar
PubMed
Search for other papers by Emily D Szmuilowicz in
Google Scholar
PubMed
based upon intracellular glycation of hemoglobin molecules within red blood cells, any pathophysiological state that alters red blood cell lifespan can make HbA1c less reliable as a measure of glycemic control. Conditions that alter red blood cell